Atalaya Capital Management’s European Biotech Acquisition Corp. Class A Ordinary Shares EBAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-40,000
| Closed | -$404K | – | 296 |
|
|
2022
Q4 | $404K | Hold |
40,000
| – | – | 0.07% | 118 |
|
|
2022
Q3 | $397K | Hold |
40,000
| – | – | 0.05% | 163 |
|
|
2022
Q2 | $391K | Hold |
40,000
| – | – | 0.05% | 174 |
|
|
2022
Q1 | $390K | Hold |
40,000
| – | – | 0.04% | 201 |
|
|
2021
Q4 | $388K | Hold |
40,000
| – | – | 0.04% | 216 |
|
|
2021
Q3 | $387K | Hold |
40,000
| – | – | 0.06% | 155 |
|
|
2021
Q2 | $386K | Buy |
+40,000
| New | +$386K | 0.1% | 146 |
|